CA3238321A1 - A vvn001-containing ophthalmic composition - Google Patents
A vvn001-containing ophthalmic compositionInfo
- Publication number
- CA3238321A1 CA3238321A1 CA3238321A CA3238321A CA3238321A1 CA 3238321 A1 CA3238321 A1 CA 3238321A1 CA 3238321 A CA3238321 A CA 3238321A CA 3238321 A CA3238321 A CA 3238321A CA 3238321 A1 CA3238321 A1 CA 3238321A1
- Authority
- CA
- Canada
- Prior art keywords
- vvn001
- solution
- composition containing
- ophthalmic composition
- ophthalmic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310476403.2A CN118892446A (zh) | 2023-04-27 | 2023-04-27 | 一种含vvn001的眼科组合物 |
| CN202310476403.2 | 2023-04-27 | ||
| PCT/CN2023/096273 WO2024221527A1 (zh) | 2023-04-27 | 2023-05-25 | 一种含vvn001的眼科组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3238321A1 true CA3238321A1 (en) | 2025-07-08 |
Family
ID=93255459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3238321A Pending CA3238321A1 (en) | 2023-04-27 | 2023-05-25 | A vvn001-containing ophthalmic composition |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4702974A1 (https=) |
| JP (1) | JP2025516407A (https=) |
| KR (1) | KR20240159657A (https=) |
| CN (1) | CN118892446A (https=) |
| AU (1) | AU2023361985B2 (https=) |
| CA (1) | CA3238321A1 (https=) |
| IL (1) | IL312531A (https=) |
| TW (1) | TW202442220A (https=) |
| WO (1) | WO2024221527A1 (https=) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0589020A4 (en) * | 1992-03-18 | 1994-07-06 | Coopervision Pharma | Verapamil hcl formulation and other ophthalmic solutions with buffer system for ocular administration |
| US5800807A (en) * | 1997-01-29 | 1998-09-01 | Bausch & Lomb Incorporated | Ophthalmic compositions including glycerin and propylene glycol |
| HUE059052T2 (hu) * | 2014-11-07 | 2022-10-28 | Santen Pharmaceutical Co Ltd | Vizes szemészeti készítmény |
| WO2019001171A1 (zh) * | 2017-06-27 | 2019-01-03 | 维眸生物科技上海有限公司 | 一种含磷化合物及其制备和应用 |
| CN109134533B (zh) * | 2017-06-27 | 2020-08-11 | 维眸生物科技（上海）有限公司 | 一种含磷化合物及其制备和应用 |
| CN114533652B (zh) * | 2018-09-25 | 2024-12-13 | 沈阳兴齐眼药股份有限公司 | 药物组合物、其制备方法和用途 |
| US20230172946A1 (en) * | 2019-08-18 | 2023-06-08 | Iview Therapeutics, Inc. | In-situ Gel Forming Ophthalmic Formulations Containing Difluprednate |
| IT202000027155A1 (it) * | 2020-11-12 | 2022-05-12 | Sifi Spa | Formulazione a base di poliesametilene biguanide per il trattamento della cheratite da acanthamoeba |
| PL4312986T3 (pl) * | 2021-04-01 | 2025-02-17 | Active Biotech Ab | Preparat lakwinimodu do stosowania do oczu |
-
2023
- 2023-04-27 CN CN202310476403.2A patent/CN118892446A/zh active Pending
- 2023-05-25 CA CA3238321A patent/CA3238321A1/en active Pending
- 2023-05-25 AU AU2023361985A patent/AU2023361985B2/en active Active
- 2023-05-25 KR KR1020247022421A patent/KR20240159657A/ko active Pending
- 2023-05-25 JP JP2023560923A patent/JP2025516407A/ja active Pending
- 2023-05-25 WO PCT/CN2023/096273 patent/WO2024221527A1/zh not_active Ceased
- 2023-05-25 EP EP23887181.8A patent/EP4702974A1/en active Pending
- 2023-10-24 TW TW112140586A patent/TW202442220A/zh unknown
-
2024
- 2024-05-01 IL IL312531A patent/IL312531A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202442220A (zh) | 2024-11-01 |
| EP4702974A1 (en) | 2026-03-04 |
| JP2025516407A (ja) | 2025-05-30 |
| CN118892446A (zh) | 2024-11-05 |
| AU2023361985A1 (en) | 2024-11-14 |
| KR20240159657A (ko) | 2024-11-05 |
| AU2023361985B2 (en) | 2025-08-14 |
| IL312531A (en) | 2024-11-01 |
| WO2024221527A1 (zh) | 2024-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3910041A4 (en) | Composition containing trans-1,2-difluoroethylene | |
| PE20170947A1 (es) | 2-amino-3,5-difluoro-6-metil-6-fenil-3,4,5,6-tetrahidropiridinas en calidad de inhibidores de bace1 | |
| EP4301586A4 (en) | VITRIMERS CONTAINING ADDITIVES | |
| EP4429704A4 (en) | IONIC LIQUID COMPOSITIONS | |
| EP4129275A4 (en) | COMPOSITION CONTAINING MENTHOL | |
| EP3897732A4 (en) | COMPOSITION CONTAINING CANNABINOIDS | |
| EP4015002A4 (en) | ORAL PHARMACEUTICAL COMPOSITION CONTAINING A HETEROCYCLIC COMPOUND | |
| EP4190709A4 (en) | Can container | |
| EP4104828A4 (en) | Diclofenac sodium-containing patch | |
| CA3238321A1 (en) | A vvn001-containing ophthalmic composition | |
| EP3939955A4 (en) | Composition containing 1,1,2-trifluoroethane | |
| EP3888647A4 (en) | EZH1/2 DUAL INHIBITOR CONTAINING PHARMACEUTICAL COMPOSITION FOR USE AS COMBINATION MEDICINAL PRODUCT | |
| EP4424676A4 (en) | Pyridyl-containing compound | |
| EP3831373A4 (en) | SOLID MEDICINAL FORMULATION CONTAINING STABILIZER | |
| EP4119533A4 (en) | Novel borate compound-containing composition | |
| EP4197540A4 (en) | DRUG FORMULATION CONTAINING SEPETAPROST | |
| EP4039248C0 (en) | Ophthalmic composition | |
| EP4144731A4 (en) | COMPOUNDS CONTAINING BENZOSULTAM | |
| EP3927340A4 (en) | PHARMACEUTICAL COMPOSITION WITH BENZIMIDAZOLE DERIVATIVE COMPOUND | |
| EP4393949A4 (en) | PHARMACEUTICAL COMPOSITION WITH FUSION PROTEIN | |
| EP4308477C0 (en) | Container | |
| EP3950332A4 (en) | SOLUTION COMPOSITION CONTAINING CONDUCTIVE POLYMER | |
| EP4505536A4 (en) | ELECTRODE COMPOSITIONS | |
| EP3946868A4 (en) | PELLETS WITH ADDITIVES | |
| EP4553110A4 (en) | COMPOSITION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - SMALL Year of fee payment: 2 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250507 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250509 |
|
| Q12 | Application published |
Free format text: ST27 STATUS EVENT CODE: A-2-2-Q10-Q12-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION PUBLISHED (OPEN TO PUBLIC INSPECTION) Effective date: 20250708 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20251008 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20251127 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20251202 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20251203 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20251203 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - SMALL Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260309 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260309 |